Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Year of publication
- 2017 (13) (remove)
Document Type
- Journal article (10)
- Conference Proceeding (1)
- Doctoral Thesis (1)
- Complete part of issue (1)
Language
- English (10)
- German (2)
- Multiple languages (1)
Keywords
- CNS (2)
- EAE (2)
- experimental autoimmune encephalomyelitis (2)
- multiple sclerosis (2)
- 18F-FDG (1)
- Atlantischer Wildkohl (1)
- B cells (1)
- Brassica oleracea (1)
- Brombeerart (1)
- Brombeere (1)
Institute
- Institut für Anatomie und Zellbiologie (13) (remove)
Sonstige beteiligte Institutionen
Der Atlantische Wildkohl (Brassica oleracea L. subsp. oleracea) wächst auf den Küstenfelsen des Atlantiks und der Nordsee zwischen Nord-Spanien, Schottland und der Nordseeinsel Helgoland. 2001 wurde auch ein Vorkommen des Wildkohls an den Kreidefelsen der Ostseeinsel Rügen nachgewiesen, das aus ungefähr 50 Individuen besteht. Die Pflanzen unterscheiden sich phänotypisch nicht von Wildpflanzen der Atlantikküsten. Da alle verbreiteten Kultursorten des Gemüsekohls genetisch sehr eng mit dem Atlantischen Kohl verwandt sind, vom dem sie höchstwahrscheinlich abstammen, wird die Frage erörtert, ob eine spontane Rückverwandlung (Rückkreuzung) von in die Natur entwichenen Kultursorten in den Wildkohl-Phänotyp möglich ist. Dieses wird als wenig wahrscheinlich angesehen. Dagegen ist Introgression zwischen Kultursorten und Wildsorten gut belegt. Die Frage nach einer möglichen Hybridisierung von Grünkohl mit Pflanzen vom Wildkohlphänotyp oder mit anderen Kultursorten an der Kreideküste der dänischen Ostseeinsel Seeland wird anhand eigener Beobachtungen erörtert. Die dortige Population besteht offensichtlich aus verwilderten Kulturkohlhybriden, die sich deutlich von den Wildpflanzen Rügens unterscheiden. Das neue Vorkommen des Atlantischen Wildkohls in der westlichen Ostsee kann im Zusammenhang mit der Ostausbreitung anderer atlantischer Sippen im Rahmen des Klimawandels gesehen werden.
Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
(2017)
Background:
MP4-induced experimental autoimmune encephalomyelitis (EAE) is a mouse model of multiple sclerosis (MS), which enables targeted research on B cells, currently much discussed protagonists in MS pathogenesis. Here, we used this model to study the impact of the S1P1 receptor modulator FTY720 (fingolimod) on the autoreactive B cell and antibody response both in the periphery and the central nervous system (CNS).
Methods:
MP4-immunized mice were treated orally with FTY720 for 30 days at the peak of disease or 50 days after EAE onset. The subsequent disease course was monitored and the MP4-specific B cell/antibody response was measured by ELISPOT and ELISA. RNA sequencing was performed to determine any effects on B cell-relevant gene expression. S1P\(_{1}\) receptor expression by peripheral T and B cells, B cell subset distribution in the spleen and B cell infiltration into the CNS were studied by flow cytometry. The formation of B cell aggregates and of tertiary lymphoid organs (TLOs) was evaluated by histology and immunohistochemistry. Potential direct effects of FTY720 on B cell aggregation were studied in vitro.
Results:
FTY720 significantly attenuated clinical EAE when treatment was initiated at the peak of EAE. While there was a significant reduction in the number of T cells in the blood after FTY720 treatment, B cells were only slightly diminished. Yet, there was evidence for the modulation of B cell receptor-mediated signaling upon FTY720 treatment. In addition, we detected a significant increase in the percentage of B220\(^{+}\) B cells in the spleen both in acute and chronic EAE. Whereas acute treatment completely abrogated B cell aggregate formation in the CNS, the numbers of infiltrating B cells and plasma cells were comparable between vehicle- and FTY720-treated mice. In addition, there was no effect on already developed aggregates in chronic EAE. In vitro B cell aggregation assays suggested the absence of a direct effect of FTY720 on B cell aggregation. However, FTY720 impacted the evolution of B cell aggregates into TLOs.
Conclusions:
The data suggest differential effects of FTY720 on the B cell compartment in MP4-induced EAE.
In vitro models of the human blood-brain barrier (BBB) are highly desirable for drug development. This study aims to analyze a set of ten different BBB culture models based on primary cells, human induced pluripotent stem cells (hiPSCs), and multipotent fetal neural stem cells (fNSCs). We systematically investigated the impact of astrocytes, pericytes, and NSCs on hiPSC-derived BBB endothelial cell function and gene expression. The quadruple culture models, based on these four cell types, achieved BBB characteristics including transendothelial electrical resistance (TEER) up to 2,500 Ω cm\(^{2}\) and distinct upregulation of typical BBB genes. A complex in vivo-like tight junction (TJ) network was detected by freeze-fracture and transmission electron microscopy. Treatment with claudin-specific TJ modulators caused TEER decrease, confirming the relevant role of claudin subtypes for paracellular tightness. Drug permeability tests with reference substances were performed and confirmed the suitability of the models for drug transport studies.